Highly Pathogenic Avian Influenza (HPAI) and African Swine Fever (ASF) have reshaped global livestock health priorities. Since 2022, U.S. HPAI outbreaks have affected over 168 million birds across 1,689 confirmed flocks, forcing depopulation and creating sustained vaccine demand. China's African Swine Fever recovery program, India's $25 million G20 Pandemic Fund, and the EU vaccination campaign for HPAI in France have established outbreak response as a strategic category. Boehringer Ingelheim's VAXXITEK HVT+IBD+H5 combines avian influenza, infectious bursal disease, and Marek's disease in a single vector vaccine. Ceva Santé Animale leads the poultry vaccine market through hatchery vaccination services. Multiple suppliers — Zoetis, Merck Animal Health, Hipra, Merial — are advancing ASF vaccine candidates with the most advanced programs entering Phase III trials.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Outbreak Response Vaccine Market Size, Growth and Forecast 2025-2030
• Highly Pathogenic Avian Influenza (HPAI) Vaccines — Inactivated, Vector, mRNA
• Hatchery Vaccination Services — Ceva CHICK Program and Competitor Approaches
• African Swine Fever Vaccine Pipeline — Live Attenuated, Subunit, mRNA
• Foot-and-Mouth Disease Vaccines — Established Programs and New Strains
• Bovine Respiratory Disease and BVDV Vaccine Innovation
• Outbreak Surveillance and Diagnostic Platforms
• Regulatory Landscape — USDA APHIS, OIE/WOAH, EMA Approval Pathways
• Government Procurement and Stockpiling Programs
• Manufacturing Capacity and Surge Production Capability
• Market Challenges and Risks — Strain Drift, Trade Implications, Vaccine Efficacy
Table of Contents
1. Executive Summary
2. Market Overview
3. Outbreak Response Vaccine Market Size, Growth and Forecast 2025-2030
4. Highly Pathogenic Avian Influenza Vaccines
5. Hatchery Vaccination Services
6. African Swine Fever Vaccine Pipeline
7. Foot-and-Mouth Disease Vaccines
8. Bovine Respiratory Disease and BVDV
9. Outbreak Surveillance and Diagnostics
10. Regulatory Landscape
11. Government Procurement and Stockpiling
12. Manufacturing Capacity
13. Regional Analysis
14. Market Challenges and Risks
15. Competitive Landscape
16. Strategic Conclusions and Recommendations
17. Appendix
List of Tables
Table 1. Outbreak Response Vaccine Market Size and Forecast 2025-2030
Table 2. HPAI Outbreaks and Bird Loss by Region 2022-2026
Table 3. Avian Influenza Vaccine Sales by Supplier and Platform
Table 4. Hatchery Vaccination Service Market by Provider
Table 5. ASF Vaccine Pipeline by Supplier and Development Stage
Table 6. Foot-and-Mouth Disease Vaccine Market by Region
Table 7. Bovine Respiratory Disease Vaccine Sales by Supplier
Table 8. Government Stockpile and Procurement Programs by Country
Table 9. Manufacturing Capacity by Supplier and Disease
Table 10. Competitive Positioning by Disease and Vaccine Platform
Companies Profiled
Boehringer Ingelheim Animal Health
Ceva Santé Animale
Elanco Animal Health
Hipra
Merck Animal Health
Phibro Animal Health
Vetoquinol
Virbac
Zoetis
